Surrey Research Park
10 Nugent Road
Guildford GU2 7AF
44 14 8334 3434
Industry: Diagnostics & Research
|Mr. Andrew David William Newland||Founder, CEO & Exec. Director||446k||N/A||1962|
|Mr. Ian Francis Griffiths||CFO, Fin. Director, Company Sec. & Exec. Director||284k||N/A||1965|
|Mr. Martin Cooke||Director of Operations & Regulatory Affairs||N/A||N/A||1969|
|Mr. Andrew John Holder||Head of Investor Relations||N/A||N/A||1968|
|Dr. Madeline Repollet||Head of Clinical Laboratories||N/A||N/A||N/A|
|Ms. Anne-Sophie Pailhes-Jimenez||Head of R&D - ANGLE Europe Ltd.||N/A||N/A||N/A|
|Mr. Brett Swansiger||Chief Commercial Officer||N/A||N/A||N/A|
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
ANGLE plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.